Volume | 35,801 |
|
|||||
News | - | ||||||
Day High | 0.7001 | Low High |
|||||
Day Low | 0.600101 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ThermoGenesis Holdings Inc | THMO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.6975 | 0.600101 | 0.7001 | 0.63 | 0.7011 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
190 | 35,801 | $ 0.6534376 | $ 23,394 | - | 0.3606 - 2.98 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:56:05 | 20 | $ 0.6233 | USD |
ThermoGenesis Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
16.12M | 3.14M | - | 10.48M | -11.27M | -3.59 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ThermoGenesis News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical THMO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.8397 | 0.91 | 0.600101 | 0.7584839 | 23,754 | -0.2097 | -24.97% |
1 Month | 0.779 | 0.9698 | 0.600101 | 0.7812202 | 30,936 | -0.149 | -19.13% |
3 Months | 0.4008 | 1.25 | 0.3606 | 0.7821114 | 88,999 | 0.2292 | 57.19% |
6 Months | 1.12 | 1.25 | 0.3606 | 0.7675974 | 81,512 | -0.49 | -43.75% |
1 Year | 2.31 | 2.98 | 0.3606 | 1.22 | 112,901 | -1.68 | -72.73% |
3 Years | 110.70 | 141.9525 | 0.3606 | 17.09 | 651,919 | -110.07 | -99.43% |
5 Years | 241.65 | 638.10 | 0.3606 | 80.63 | 662,308 | -241.02 | -99.74% |
ThermoGenesis Description
ThermoGenesis Holdings Inc. develops commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking point-of-care applications and automation for immuno-oncology including its semi-automated functionally-closed CAR-TXpress platform which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. |